You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clinical trial, phase II

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

(Phase 1) - A Nationwide Multicentre Cross-Sectional Study

Completed
  • SARS-CoV Infection
  • +3 more
  • Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances
  • Kluang, Johor, Malaysia
  • +13 more
Feb 23, 2021

(Phase 2) - A Nationwide Multicentre Case-Control Study

Recruiting
  • SARS-CoV Infection
  • +3 more
  • Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances
  • Kluang, Johor, Malaysia
  • +13 more
Feb 23, 2021

Diabetic Foot Ulcer, Diabetes, Wounds Trial in Kaohsiung (CSTC1, CSTC1 Matched vehicle)

Completed
Has Results
  • Diabetic Foot Ulcer
  • +2 more
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Chung-Ho Memorial Hospital
Feb 14, 2022

HIV Trial in United States (GEO-D03 DNA vaccine, MVA/HIV62B (MVA62B) vaccine, Placebo for GEO-D03 DNA)

Completed
  • HIV Infections
  • GEO-D03 DNA vaccine
  • +3 more
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021

Patients on Treatment With Systemic Steroids Trial in Seoul (Lansoprazole, Fexuprazan Hydrochloride)

Not yet recruiting
  • Patients on Treatment With Systemic Steroids
  • Seoul, Korea, Republic of
    Severance Hospital
Jul 6, 2023

Cushing Disease Trial in Los Angeles (Seliciclib)

Active, not recruiting
  • Cushing Disease
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 24, 2022

Oligometastatic Gastrointestinal Cancer Trial in Shanghai (Stereotactic Ablative Radiotherapy (SABR), Camrelizumab for injection

Not yet recruiting
  • Oligometastatic Gastrointestinal Cancer
  • Stereotactic Ablative Radiotherapy (SABR)
  • Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 6, 2020

Effect of Platelet Rich Fibrin With Different Tooth Movements Trial in Cairo (injectable platelet rich fibrin)

Enrolling by invitation
  • Effect of Platelet Rich Fibrin With Different Tooth Movements
  • injectable platelet rich fibrin
  • Cairo, Egypt
    AlAzhar university
Nov 9, 2022

Extensive-stage Small Cell Lung Cancer Trial in Shanghai (AL3810, carboplatin + etoposide, Placebo)

Unknown status
  • Extensive-stage Small Cell Lung Cancer
  • Shanghai, China
    Shanghai Chest Hospital
Feb 3, 2020

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023

HIV Trial in United States (Atevirdine mesylate, Zidovudine, Didanosine)

Completed
  • HIV Infections
  • Atevirdine mesylate
  • +2 more
  • Los Angeles, California
  • +4 more
Oct 27, 2021

Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)

Recruiting
  • Tuberous Sclerosis Complex
  • Epilepsy
  • Birmingham, Alabama
  • +7 more
Sep 2, 2022

Metastatic Malignant Tumor in the Lung, Metastatic Osteosarcoma, Osteosarcoma Trial in Canada, United States (Questionnaire

Recruiting
  • Metastatic Malignant Neoplasm in the Lung
  • +2 more
  • Questionnaire Administration
  • +2 more
  • Birmingham, Alabama
  • +152 more
Dec 28, 2022

Meningioma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Meningioma
  • Hyperpolarized carbon C 13 pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 23, 2023

Frailty, Oncology Problem, Cognitive Impairment Trial in Halifax (Geriatric assessment)

Not yet recruiting
  • Frailty
  • +2 more
  • Geriatric assessment
  • Halifax, Nova Scotia, Canada
    QEII, Victoria General Hospital
Aug 31, 2023

Pulmonary Arterial Hypertension Trial in Edmonton, Toronto, Quebec City (Olaparib)

Recruiting
  • Pulmonary Arterial Hypertension
  • Edmonton, Alberta, Canada
  • +2 more
May 25, 2022

Uterine Leiomyoma Trial in Cairo (Dienogest 2 MG, N-acetyl cysteine)

Recruiting
  • Uterine Leiomyoma
  • Dienogest 2 MG
  • N-acetyl cysteine
  • Cairo, Egypt
    Ainshams University
Oct 29, 2023

GVHD Trial in United States (Abatacept)

Recruiting
  • Graft Versus Host Disease
  • Birmingham, Alabama
  • +8 more
Mar 16, 2022

Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,

Active, not recruiting
  • Colon Adenocarcinoma
  • +18 more
  • Cetuximab
  • +5 more
  • Anchorage, Alaska
  • +797 more
Jan 9, 2023

Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage Trial in United Kingdom (Apixaban,

Completed
  • Intracranial Hemorrhages
  • +8 more
  • Edinburgh, Midlothian, United Kingdom
  • +66 more
Mar 31, 2022

Colon Cancer Trial in Worldwide (Aspirin, Placebo)

Active, not recruiting
  • Colon Cancer
  • Brussels, Belgium
  • +51 more
Mar 10, 2022

MERS (Middle East Respiratory Syndrome) Trial in Hamburg, Rotterdam (MVA-MERS-S_DF1 - Low Dose, MVA-MERS-S_DF1 - High Dose,

Recruiting
  • MERS (Middle East Respiratory Syndrome)
  • MVA-MERS-S_DF1 - Low Dose
  • +2 more
  • Hamburg, Germany
  • +1 more
Aug 1, 2021

Ovarian Cancer Trial in Worldwide (NovoTTF-100L(O), Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +118 more
Apr 19, 2022

Advanced Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in Seattle

Terminated
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • Cabozantinib S-malate
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 12, 2022

Acute Otitis Externa Trial in Shanghai (Ciprofloxacin-Fluocinolone Acetonide, 0.3%-0.025% Otic Solution, Ciprofloxacin 0.3%

Not yet recruiting
  • Acute Otitis Externa
  • Ciprofloxacin-Fluocinolone Acetonide, 0.3%-0.025% Otic Solution
  • Ciprofloxacin 0.3% solution
  • Shanghai, China
    Eye & Ent Hospital of Fudan University
Nov 13, 2020